Clinical Trial Update: Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results evaluating the efficacy and safety of roflumilast cream in Atopic Dermatitis have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Roflumilast Cream (roflumilast)

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Atopic Dermatitis (AD) | Phase 3 | Status: COMPLETED